온바디 주사기 시장 : 기술별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

On-body Injectors Market size was valued at USD 4,897 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

On-body Injectors are wearable drug delivery devices designed to administer medications subcutaneously over a specific period, offering convenience and precision in chronic disease management. These devices enable self-administration of large-volume biologics and improve patient compliance by reducing the need for frequent hospital visits. With advanced features like programmable dosing, they cater to treatments for conditions such as diabetes, rheumatoid arthritis, and cancer. On-body injectors integrate cutting-edge technology to ensure ease of use, patient comfort, and safety, making them a significant innovation in personalized medicine and home-based healthcare solutions.

On-body Injectors Market- Market Dynamics

Rising prevalence of chronic diseases to fuel market growth

The on-body injectors market is driven by the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and cancer, which require consistent drug administration. These wearable devices enable patients to self-administer medication with minimal discomfort, improving adherence and convenience. Technological advancements, including integration with digital platforms for monitoring and feedback, further boost their adoption. Additionally, the shift toward biologics and specialty medications has increased the need for efficient drug delivery systems like on-body injectors. Key factors such as the growing geriatric population, demand for minimally invasive solutions, and support from regulatory bodies foster the market's growth.

On-body Injectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on Technology segmentation, spring-based segment were predicted to show maximum market share in the year 2023

Based on Application segmentation, rheumatoid arthritis was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

On-body Injectors Market- Segmentation Analysis:

The Global On-body Injectors Market is segmented on the basis of Technology, Application, End-Use, and Region. The auto-injector market is primarily divided into two segments based on Technology: Spring-based, Motor-driven, Rotary Pump and Expanding Battery and Other. The spring-based segment dominated the market. These on-body injectors offer numerous benefits to patients and healthcare providers. By delivering medication at consistent pressure and speed, they ensure accurate and reliable dosing, which is particularly essential for therapies requiring precision, such as insulin for diabetes or biologics for autoimmune diseases. This mechanism minimizes the potential for errors associated with manual injections, enhancing treatment safety and efficiency. Their controlled delivery system also supports patient comfort and compliance, making them a preferred choice in various clinical applications.

Based on application into: Oncology, Diabetes, Cardiovascular Disease, Autoimmune Disease and Others. The diabetes segment accounted for the largest market share in 2023. On-body injectors are wearable drug delivery devices designed to administer medications over an extended period, enhancing patient convenience and compliance. In oncology, they deliver precise doses of chemotherapy drugs, minimizing hospital visits. For diabetes, they ensure controlled insulin delivery, providing a flexible alternative to traditional injections. In cardiovascular diseases, these devices administer anticoagulants or other critical drugs to manage conditions effectively. Autoimmune diseases benefit from on-body injectors for regular biologic therapies, reducing the need for frequent clinical visits. Additionally, they are used in other therapeutic areas like pain management and hormone therapies, offering reliable and personalized drug administration solutions.

Based on end-use the market is segmented as Homecare Settings, Hospitals & Clinics and Ambulatory Surgical Centers. The homecare settings segment dominated the market. On-body Injectors are increasingly popular in homecare settings, as they allow patients to safely and easily administer their medications on their own. This convenience reduces the need for frequent healthcare visits, making treatments more accessible and efficient for individuals managing chronic conditions. The rise of these devices in homecare is a key factor contributing to the segment's rapid growth.

On-body Injectors Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The on-body injectors market is experiencing significant growth due to increasing demand for self-administration drug systems, particularly for chronic diseases such as diabetes and autoimmune conditions. North America dominates the market, driven by advanced healthcare infrastructure and high adoption of innovative technologies. Europe follows closely, fueled by supportive government initiatives and a growing aging population. The Asia-Pacific region is emerging as a key growth area due to rising healthcare investments, expanding patient pools, and increased awareness about advanced drug delivery systems. Meanwhile, the Middle East & Africa and Latin America exhibit steady growth, primarily due to improving healthcare access and infrastructure development.

On-body Injectors Market- Competitive Landscape:

The competitive landscape of the on-body injectors market is marked by the presence of leading healthcare and pharmaceutical companies driving innovation in wearable drug delivery systems. Key players like Medtronic plc, Insulet Corporation, Ypsomed, and West Pharmaceutical Services dominate the market with advanced solutions tailored for chronic disease management. Other notable companies, such as Enable Injections and Becton, Dickinson and Company (BD), focus on precision, user-friendly designs, and integration with digital health platforms. The competition is further fueled by partnerships and acquisitions, enabling companies to expand their portfolios and enhance their technological capabilities to meet growing patient and healthcare demands globally.

Recent Developments:

In February 2024, Coherus BioSciences, Inc. launched its UDENYCA ONBODY, a novel wearable injector for delivering pegfilgrastim, which reduces infection risk during chemotherapy. The device enhances patient convenience by minimizing hospital visits.

In October 2023, the U.S. FDA approved the Empaveli Injector, an on-body injector for the self-administration of pegcetacoplan. This device allows patients to administer their health irrespective of their location.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ON-BODY INJECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Insulet Corporation
• BD (Becton, Dickinson and Company)
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG
• Medtronic plc
• Enable Injections
• Roche
• Eli Lilly and Company
• Amgen Inc.
• CeQur SA
• Others

GLOBAL ON-BODY INJECTORS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Other

GLOBAL ON-BODY INJECTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Oncology
• Diabetes
• Cardiovascular Disease
• Autoimmune Disease
• Others

GLOBAL ON-BODY INJECTORS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

• Hospitals & Clinics
• Home Care Settings
• Others

GLOBAL ON-BODY INJECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. On-body Injectors Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. On-body Injectors Market Snippet by Technology
  • 2.1.2. On-body Injectors Market Snippet by Application
  • 2.1.3. On-body Injectors Market Snippet by End-Use
  • 2.1.4. On-body Injectors Market Snippet by Country
  • 2.1.5. On-body Injectors Market Snippet by Region
• 2.2. Competitive Insights

3. On-body Injectors Key Market Trends

• 3.1. On-body Injectors Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. On-body Injectors Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. On-body Injectors Market Opportunities
• 3.4. On-body Injectors Market Future Trends

4. On-body Injectors Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. On-body Injectors Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. On-body Injectors Market Landscape

• 6.1. On-body Injectors Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. On-body Injectors Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
  • 7.1.2. Spring-based
  • 7.1.3. Motor-driven
  • 7.1.4. Rotary Pump
  • 7.1.5. Expanding Battery
  • 7.1.6. Other

8. On-body Injectors Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Oncology
  • 8.1.3. Diabetes
  • 8.1.4. Cardiovascular Disease
  • 8.1.5. Autoimmune Disease
  • 8.1.6. Others

9. On-body Injectors Market - By End-Use

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
  • 9.1.2. Homecare Settings
  • 9.1.3. Hospitals & Clinics
  • 9.1.4. Ambulatory Surgical Centers

10. On-body Injectors Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. On-body Injectors Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. On-body Injectors Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. On-body Injectors Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. On-body Injectors Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. On-body Injectors Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- On-body Injectors Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Insulet Corporation
  • 11.2.2. BD (Becton, Dickinson and Company)
  • 11.2.3. West Pharmaceutical Services, Inc.
  • 11.2.4. Ypsomed Holding AG
  • 11.2.5. Medtronic plc
  • 11.2.6. Enable Injections
  • 11.2.7. Roche
  • 11.2.8. Eli Lilly and Company
  • 11.2.9. Amgen Inc.
  • 11.2.10. CeQur SA
  • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us